Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Lorraine E. Reeve.
International Journal of Pharmaceutics | 1999
LuAnn Erlich; Danny Yu; David A. Pallister; R.Saul Levinson; Dilip Gole; Paul Wilkinson; Ronald E. Erlich; Lorraine E. Reeve; Tacey X. Viegas
Danazol was dissolved in non-aqueous mixtures containing either polyethylene glycol 400 or polysorbate 80, and filled into hard gelatin capsules at 50 mg concentrations. The bioavailability of these formulations was compared with commercial danazol capsules in a two-way crossover study using young female beagle dogs. Both formulations showed greater oral bioavailability when compared with either the 100 or 200 mg commercial brand of danazol. The bioavailability of the polyethylene glycol 400 and polysorbate 80 formulations was enhanced 3.7 and 15.8 times, respectively, when compared at the 100 mg dose level.
Archive | 1993
Tacey X. Viegas; Lorraine E. Reeve; Raymond L. Henry
Archive | 1991
Tacey X. Viegas; Lorraine E. Reeve; Robert Saul Levinson
Archive | 1991
Tacey X. Viegas; Lorraine E. Reeve; Robert Saul Levinson
Archive | 1991
Tacey X. Viegas; Lorraine E. Reeve; Robert Saul Levinson
Archive | 1992
Tacey X. Viegas; Lorraine E. Reeve; Robert Saul Levinson
Archive | 1990
Tacey X. Viegas; Lorraine E. Reeve; Raymond L. Henry
Archive | 1990
Tacey X. Viegas; Lorraine E. Reeve; Raymond L. Henry
Archive | 1990
Tacey X. Viegas; Lorraine E. Reeve; Raymond L. Henry
Archive | 1990
Tacey X. Viegas; Lorraine E. Reeve; Raymond L. Henry